Elopak ASA
Norway · NO0011002586 · reports in EUR · Europe
Four figures
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Revenue growth
- Revenue +4.2% in the year to Dec 31, 2025, on the year before.
- Return on equity
- It earned 18% on its shareholders' equity in the year to Dec 31, 2025.
- Equity and assets
- Equity is 33% of its assets, and operations brought in cash in the year.
- Price and earnings
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in EUR.
€1.2B
revenue
9.0%
operating margin
€62M
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | €1.0B | €1.1B | €1.2B | €1.2B |
| Operating profit | €42M | €103M | €99M | €108M |
| Net profit to shareholders | €11M | €67M | €61M | €62M |
| Earnings per share | €0.04 | €0.25 | €0.23 | €0.23 |
| Dividend per share | €0.75 | n/a | n/a | €0.13 |
| Cash from operations | €25M | €155M | €139M | €171M |
| Cash | €26M | €13M | €28M | €62M |
| Total assets | €956M | €963M | €1.1B | €1.1B |
| Equity | €268M | €315M | €353M | €348M |
What they do
In the company's own words, from the annual report.
Elopak is a global supplier of liquid carton packaging and filling equipment, catering to both the fresh and aseptic segments.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the ratios from the filed figures.